Friday, November 27, 2020 7:44:56 AM
“Rhythm Pharmaceuticals Announces FDA Approval of IMCIVREE™(setmelanotide) as First-ever Therapy for Chronic Weight Management in Patients with Obesity Due to POMC, PCSK1 or LEPR Deficiency”
Another good news - voucher that they can sell or use for next approval
“With this approval, the FDA issued a Rare Pediatric Disease Priority Review Voucher (PRV) to Rhythm. The PRV can be redeemed to receive priority review for any subsequent marketing application or sold or transferred to other companies for their programs.”
https://finance.yahoo.com/news/rhythm-pharmaceuticals-announces-fda-approval-123000486.html
Recent RYTM News
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/07/2024 08:43:31 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/07/2024 11:10:20 AM
- Rhythm Pharmaceuticals Reports First Quarter 2024 Financial Results and Business Update • GlobeNewswire Inc. • 05/07/2024 11:00:00 AM
- Rhythm Pharmaceuticals Presents Data from Phase 3 Pediatrics Trial at Pediatric Endocrine Society Annual Meeting • GlobeNewswire Inc. • 05/06/2024 12:00:00 PM
- Rhythm Pharmaceuticals Announces Publication of Results from Phase 2 Study of Setmelanotide for the Treatment of Hypothalamic Obesity in The Lancet Diabetes & Endocrinology • GlobeNewswire Inc. • 04/29/2024 10:30:00 PM
- Rhythm Pharmaceuticals to Report First Quarter 2024 Financial Results on Tuesday, May 7, 2024 • GlobeNewswire Inc. • 04/24/2024 08:01:00 PM
- Rhythm Pharmaceuticals Announces New Employment Inducement Grants • GlobeNewswire Inc. • 04/16/2024 08:01:00 PM
- Rhythm Pharmaceuticals Secures $150 Million in Convertible Preferred Stock Financing • GlobeNewswire Inc. • 04/01/2024 12:00:00 PM
- Rhythm Pharmaceuticals Announces First Patient Dosed in Phase 1 Trial Evaluating RM-718, a Weekly MC4R-specific Agonist • GlobeNewswire Inc. • 03/25/2024 12:00:00 PM
- Rhythm Pharmaceuticals Announces New Employment Inducement Grants • GlobeNewswire Inc. • 03/11/2024 08:01:00 PM
- Rhythm Pharmaceuticals Announces Participation at Upcoming Investor Conferences • GlobeNewswire Inc. • 03/06/2024 09:01:00 PM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 02/29/2024 09:58:31 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/29/2024 09:46:06 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 02/29/2024 09:44:28 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 02/29/2024 09:05:53 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/22/2024 12:01:26 PM
- Rhythm Pharmaceuticals Announces Clinical Development Plan of Setmelanotide for Hypothalamic Obesity in Japan • GlobeNewswire Inc. • 02/22/2024 12:01:00 PM
- Rhythm Pharmaceuticals Reports Fourth Quarter 2023 Financial Results and Business Update • GlobeNewswire Inc. • 02/22/2024 12:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/22/2024 12:02:56 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/22/2024 12:01:57 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/22/2024 12:00:59 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/22/2024 12:00:42 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/15/2024 11:14:25 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/14/2024 01:49:16 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/14/2024 01:47:39 AM
FEATURED Cannabix Technologies Launches New Compact Breath Logix Workplace Series and Prepares for Delivery to South Africa • May 7, 2024 8:51 AM
Moon Equity Holdings, Corp. Announces Acquisition of Wikolo, Inc. • MONI • May 7, 2024 9:48 AM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM